Ranitidine Tablet
Product Images NDC 53746-253

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 53746-253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Click To Zoom In (Ranitidine Tablets Usp 1)

Chemical structure of ranitidine hydrochloride showing the molecular arrangement including nitroguanidine, thioether, furan, and dimethylaminoethyl groups.*

FDA Label Image

100 Ct. (Ranitidine Tablets Usp 2)

Ranitidine Tablets USP 150 mg oral tablets label showing the product name, strength, quantity of 100 tablets, and distributed by Amneal Pharmaceuticals of New York LLC. The label includes storage instructions, usage warnings, and a barcode.*

FDA Label Image

100 Ct. (Ranitidine Tablets Usp 3)

Label for Ranitidine Tablets USP 300 mg oral tablets by Amneal Pharmaceuticals. The label shows 100 tablets in the package, with dosage and storage information including keeping between 20° to 25°C and protecting from light. The label includes the NDC code 53746-254-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.